MwanzoGLPG • AMS
add
Galapagos NV
Bei iliyotangulia
€ 27.72
Bei za siku
€ 27.58 - € 28.30
Bei za mwaka
€ 20.00 - € 32.74
Thamani ya kampuni katika soko
1.83B EUR
Wastani wa hisa zilizouzwa
elfu 67.56
Uwiano wa bei na mapato
5.70
Mgao wa faida
-
Ubadilishanaji wa msingi
AMS
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 900.82M | 1,093.22% |
Matumizi ya uendeshaji wa biashara | 34.10M | 34.83% |
Mapato halisi | 782.15M | 2,990.63% |
Kiwango cha faida halisi | 86.83 | 159.04% |
Mapato kwa kila hisa | — | — |
EBITDA | 785.66M | 1,558.41% |
Asilimia ya kodi ya mapato | 0.09% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.00B | -3.83% |
Jumla ya mali | 3.41B | -17.63% |
Jumla ya dhima | 170.65M | -86.22% |
Jumla ya hisa | 3.24B | — |
hisa zilizosalia | 65.88M | — |
Uwiano wa bei na thamani | 0.56 | — |
Faida inayotokana na mali | 56.01% | — |
Faida inayotokana mtaji | 68.02% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 782.15M | 2,990.63% |
Pesa kutokana na shughuli | -47.46M | 20.06% |
Pesa kutokana na uwekezaji | 72.62M | 6.24% |
Pesa kutokana na ufadhili | elfu -405.00 | 74.75% |
Mabadiliko halisi ya pesa taslimu | 23.41M | 168.59% |
Mtiririko huru wa pesa | 342.01M | 1,408.71% |
Kuhusu
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Tovuti
Wafanyakazi
558
